A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma Patients to Assess the Relationship between Patient Outcomes, Treatment Regimens and Molecular Profiles
This research is being done because we hope that a better understanding of multiple myeloma will allow for more effective drugs with fewer side effects for patients with multiple myeloma. The purpose of this study is to collect, store, catalog and analyze blood samples, bone marrow samples and related health information from newly diagnosed multiple myeloma patients.
Subjects should be 18 years or older.
Subjects should have a diagnosis of symptomatic multiple myeloma.
Subjects should not already be receiving systemic therapy for multiple myeloma.
Subjects should not be enrolled in a blinded clinical trial for treatment of multiple myeloma.
18 - 99
Healthy Volunteers Needed
Duration of Participation
Clinical Trials Information Line: Phone 503-494-1080 or firstname.lastname@example.org
MMRF (Multiple Myeloma Research Foundation)